Phathom Pharmaceuticals, Inc. (PHAT) filing by Narula Sanjeev
- Filed on 2026-10-08
- Disposed of 13,485 shares at $6.78
- Owns 214,718 shares directly
Sanjeev Narula, reporting
PHAT
Phathom Pharmaceuticals, Inc. SEC filings
Every EDGAR filing for Phathom Pharmaceuticals, Inc. (PHAT), newest first, with AI summaries and stories.
- Ticker
- PHAT
- CIK
- 1783183
- Sector
- Biotech and pharma
- Latest filing
- Oct 8
Next: earnings expected ~Nov 4 · 10-Q expected ~Nov 4 (deadline Nov 16)
Insider activity
No open-market insider buys in the last 30 days.
Also: 1 grant or exercise.
Filings
4Phathom Pharmaceuticals, Inc.PHATLIVE 8-KPhathom Pharmaceuticals, Inc.PHATLIVE 4Phathom Pharmaceuticals, Inc.PHATLIVE Robert Charles Breedlove, insider filing for PHAT
Robert Charles Breedlove, reporting
10-QPhathom Pharmaceuticals, Inc.PHATLIVE 8-KPhathom Pharmaceuticals, Inc.PHATLIVE SCHEDULE 13GPhathom Pharmaceuticals, Inc.PHATLIVE Ownership stake disclosure by BlackRock, Inc.
BlackRock, Inc., filed by
SCHEDULE 13G/APhathom Pharmaceuticals, Inc.PHATLIVE Ownership stake disclosure by MILLENNIUM MANAGEMENT LLC (amended)
MILLENNIUM MANAGEMENT LLC, filed by
4Phathom Pharmaceuticals, Inc.PHATLIVE Robert Charles Breedlove, insider filing for PHAT
Robert Charles Breedlove, reporting
8-KPhathom Pharmaceuticals, Inc.PHATLIVE 4Phathom Pharmaceuticals, Inc.PHATLIVE Asit Parikh, insider filing for PHAT
Asit Parikh, reporting
4Phathom Pharmaceuticals, Inc.PHATLIVE 7 insider filings
Asit Parikh, insider filing for PHAT
Show all 7
- 4Insider filing for PHAT
- 4Insider filing for PHAT
- 4Insider filing for PHAT
- 4Insider filing for PHAT
- 4Insider filing for PHAT
- 4Insider filing for PHAT
- 4Insider filing for PHAT
Asit Parikh, reporting
8-KPhathom Pharmaceuticals, Inc.PHATLIVE 10-QPhathom Pharmaceuticals, Inc.PHATLIVE 8-KPhathom Pharmaceuticals, Inc.PHATLIVE DEFA14APhathom Pharmaceuticals, Inc.PHATLIVE ARSPhathom Pharmaceuticals, Inc.PHATLIVE DEF 14APhathom Pharmaceuticals, Inc.PHATLIVE S-8Phathom Pharmaceuticals, Inc.PHATLIVE SCHEDULE 13GPhathom Pharmaceuticals, Inc.PHATLIVE Ownership stake disclosure by MILLENNIUM MANAGEMENT LLC
MILLENNIUM MANAGEMENT LLC, filed by
4Phathom Pharmaceuticals, Inc.PHATLIVE Asit Parikh, insider filing for PHAT
Asit Parikh, reporting
4Phathom Pharmaceuticals, Inc.PHATLIVE Robert Charles Breedlove, insider filing for PHAT
Robert Charles Breedlove, reporting
10-KPhathom Pharmaceuticals, Inc.PHATLIVE 8-KPhathom Pharmaceuticals, Inc.PHATLIVE 4Phathom Pharmaceuticals, Inc.PHATLIVE 2 insider filings
Anne Marie Cook, insider filing for PHAT
Show all 2
- 4Insider filing for PHAT
- 4Insider filing for PHAT
Anne Marie Cook, reporting
4Phathom Pharmaceuticals, Inc.PHATLIVE Asit Parikh, insider filing for PHAT
Asit Parikh, reporting
SCHEDULE 13G/APhathom Pharmaceuticals, Inc.PHATLIVE Ownership stake disclosure by MILLENNIUM MANAGEMENT LLC (amended)
MILLENNIUM MANAGEMENT LLC, filed by
4Phathom Pharmaceuticals, Inc.PHATLIVE Robert Charles Breedlove, insider filing for PHAT
Robert Charles Breedlove, reporting
4Phathom Pharmaceuticals, Inc.PHATLIVE Asit Parikh, insider filing for PHAT
Asit Parikh, reporting
8-KPhathom Pharmaceuticals, Inc.PHATLIVE 424B5Phathom Pharmaceuticals, Inc.PHATLIVE 424B5Phathom Pharmaceuticals, Inc.PHATLIVE 8-KPhathom Pharmaceuticals, Inc.PHATLIVE S-3ASRPhathom Pharmaceuticals, Inc.PHATLIVE 4Phathom Pharmaceuticals, Inc.PHATLIVE 3 insider filings
Steven L Basta, insider filing for PHAT
Show all 3
- 4Insider filing for PHAT
- 4Insider filing for PHAT
- 4Insider filing for PHAT
Steven L Basta, reporting
4Phathom Pharmaceuticals, Inc.PHATLIVE Asit Parikh, insider filing for PHAT
Asit Parikh, reporting
4Phathom Pharmaceuticals, Inc.PHATLIVE 3 insider filings
Robert Charles Breedlove, insider filing for PHAT
Show all 3
- 4Insider filing for PHAT
- 4Insider filing for PHAT
- 4Insider filing for PHAT
Robert Charles Breedlove, reporting
4Phathom Pharmaceuticals, Inc.PHATLIVE Steven L Basta, insider filing for PHAT
Steven L Basta, reporting
4Phathom Pharmaceuticals, Inc.PHATLIVE Robert Charles Breedlove, insider filing for PHAT
Robert Charles Breedlove, reporting
SCHEDULE 13D/APhathom Pharmaceuticals, Inc.LIVE Ownership stake disclosure by Frazier Life Sciences Public Fund, L.P. (amended)
Frazier Life Sciences Public Fund, L.P., filed by